NCT04747223 (STRIDe) is a NA clinical trial of Run Gait Retraining in Overuse Injury, sponsored by Army-Baylor University Doctoral Program in Physical Therapy.

Who is sponsoring NCT04747223?

NCT04747223 is sponsored by Army-Baylor University Doctoral Program in Physical Therapy.

What drugs are being tested in NCT04747223?

Interventions in NCT04747223: Run Gait Retraining.

What condition does NCT04747223 study?

NCT04747223 studies Overuse Injury, Lower Extremity Problem, Stress Injury, Repetitive, Patellofemoral Pain Syndrome, Shin Splint.

Is NCT04747223 still recruiting?

NCT04747223 is currently status unknown. Last updated 10 February 2021.

Last reviewed 2021-02-10 · How we verify

NCT04747223: STRIDe

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Step Rate Retraining to Reduce Injury and Disability (STRIDe)

Status unknown NA Last updated 10 February 2021

What this trial tests

NA trial testing Run Gait Retraining in Overuse Injury in 100 participants. Status unknown.

Timeline

1 February 2021

Primary endpoint
1 June 2022

31 December 2022

Quick facts

Lead sponsor	Army-Baylor University Doctoral Program in Physical Therapy
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	100
Start date	1 February 2021
Primary completion	1 June 2022
Estimated completion	31 December 2022

Drugs / interventions tested

Run Gait Retraining

Conditions studied

Overuse Injury — all drugs for Overuse Injury →
Lower Extremity Problem — all drugs for Lower Extremity Problem →
Stress Injury, Repetitive — all drugs for Stress Injury, Repetitive →
Patellofemoral Pain Syndrome — all drugs for Patellofemoral Pain Syndrome →

Sponsor

Army-Baylor University Doctoral Program in Physical Therapy

Who can join

Adults 18 to 50, any sex, with Overuse Injury or Lower Extremity Problem. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be the first project to evaluate the effectiveness of wearable technology (Garmin Forerunner35) while performing gait retraining in field on military members. The watch will provide real time feedback to the runner on their step rate while performing running sessions outside of the lab. This allows the runner to modify their step rate to meet a recommended step rate provided by the study team member. Aim 1: To demonstrate the utility of wearable sensors to modify running step rate through real time biofeedback. Aim 2: To determine whether altering step rate using real time biofeedback reduces lower extremity musculoskeletal injury reoccurrence within 1 year post training.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Army-Baylor University Doctoral Program in Physical Therapy trials

Trials by the same sponsor.

NCT04170803 — Feasibility of Near-infrared Spectroscopy to Measure Cortical Pain Pathway (Brain) Activation During Dry Needling · EARLY_PHASE1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04747223 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Army-Baylor University Doctoral Program in Physical Therapy
Last refreshed: 10 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04747223.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing